[Mortality and survival of premature infants according to sex].

M. Giovannucci,F. Falcini

1966-06-01

Abstract:

What problem does this paper attempt to address?

Galectin-12 modulates Kupffer cell polarization to alter the progression of nonalcoholic fatty liver disease

Jyun-Lin Lee,Yao-Chien Wang,Yu-An Hsu,Chih-Sheng Chen,Rui-Cian Weng,Yen-Pei Lu,Chun-Yu Chuang,Lei Wan

DOI: https://doi.org/10.1093/glycob/cwad062

2023-01-01

Glycobiology

Abstract:Nonalcoholic fatty liver disease is caused by an imbalance in lipid metabolism and immune response to pose a risk factor for liver fibrosis. Recent evidence indicates that M2 macrophages secrete transforming growth factor-& beta;1, which contributes to liver fibrosis. Galectin-12 has been demonstrated to regulate lipid metabolism and macrophage polarization. The purpose of this study is to investigate the role of galectin-12 in the development of nonalcoholic fatty liver disease and fibrosis. Liver tissue from wild-type C57BL/6 mice fed with a high-fat diet containing cholesterol and cholic acid diet for 4-12 weeks was used to examine galectin-12 expression and its correlation with nonalcoholic fatty liver disease. Furthermore, the effects of galectin-12 on M2 macrophages during the progression of nonalcoholic fatty liver disease were investigated by studying Kupffer cells from galectin-12 knockout mice and doxycycline-inducible Gal12(-/-)THP-1 cells. Ablation of galectin-12 promoted M2 polarization of Kupffer cells, as indicated by higher levels of M2 markers, such as arginase I and chitinase 3-like protein 3. Furthermore, the activation of signal transducer and activator of transcription 6 was significantly higher in Gal12(-/-) macrophages activated by interleukin-4, which was correlated with higher levels of transforming growth factor-& beta;1. Moreover, Gal12(-/-) macrophage-conditioned medium promoted hepatic stellate cells myofibroblast differentiation, which was indicated by higher & alpha;-smooth muscle actin expression levels compared with those treated with LacZ control medium. Finally, we demonstrated that galectin-12 knockdown negatively regulated the suppressor of cytokine signaling 3 levels. These findings suggested that galectin-12 balances M1/M2 polarization of Kupffer cells to prevent nonalcoholic fatty liver disease progression.
Leukocyte Cell-Derived Chemotaxin 2 Inhibits Development of Atherosclerosis in Mice

Wen-Ming He,Ting Dai,Jiong Chen,Jian-An Wang

DOI: https://doi.org/10.24272/j.issn.2095-8137.2019.030

2019-01-01

Zoological Research

Abstract:Leukocyte cell-derived chemotaxin 2（LECT2）, a multifunctional hepatokine, is involved in many pathological conditions. However, its role in atherosclerosis remains undefined. In this study, we administered vehicle or LECT2 to male Apoe-/-mice fed a Western diet for 15 weeks. Atherosclerotic lesions were visualized and quantified with Oil-red O and hematoxylin staining. The mRNA expression levels of MCP-1, MMP-1, IL-8, IL-1β, and TNF-αwere analyzed by quantitative real-time polymerase chain reaction. Serum TNF-α, IL-1β, IL-8, MCP-1,and MMP-1 concentrations were measured by enzyme-linked immunosorbent assay. CD68, CD31,and α-SMA, markers of macrophages, endothelial cells, and smooth muscle cells, respectively, were detected by immunostaining. Results showed that LECT2 reduced total cholesterol and low-density lipoprotein concentrations in serum and inhibited the development of atherosclerotic lesions, accompanied by reductions in inflammatory cytokines and lower MCP-1, MMP-1, TNF-α, IL-8, and IL-1β mRNA abundance. Furthermore, LECT2 decreased CD68,but increased α-SMA in atherosclerotic lesions,suggesting an increase in smooth muscle cells and reduction in macrophages. In summary, LECT2 inhibited the development of atherosclerosis in mice,accompanied by reduced serum total cholesterol concentration and lower inflammatory responses.
Galectin-12 in Cellular Differentiation, Apoptosis and Polarization

Lei Wan,Ri-Yao Yang,Fu-Tong Liu

DOI: https://doi.org/10.3390/ijms19010176

IF: 5.6

2018-01-01

International Journal of Molecular Sciences

Abstract:Galectin-12 is a member of a family of mammalian lectins characterized by their affinity for β-galactosides and consensus amino acid sequences. The protein structure consists of a single polypeptide chain containing two carbohydrate-recognition domains joined by a linker region. Galectin-12 is predominantly expressed in adipose tissue, but is also detected in macrophages and other leukocytes. Downregulation of galectin-12 in mouse 3T3-L1 cells impairs their differentiation into adipocytes. Conversely, overexpression of galectin-12 in vitro induces cell cycle arrest in G1 and apoptosis. Upregulation of galectin-12 and initiation of G1 cell cycle arrest are associated with driving pre-adipocytes toward terminal differentiation. Galectin-12 deficiency increases insulin sensitivity and glucose tolerance in obese animals. Galectin-12 inhibits macrophage polarization to the M2 population, enhancing inflammation and decreasing insulin sensitivity in adipocytes. Galectin-12 also affects myeloid differentiation, which is associated with chemotherapy resistance. In addition to highlighting the above-mentioned aspects, this review also discusses the potential clinical applications of modulating the function of galectin-12.
Galectin-12 in Macrophage Polarization (INM2P.425)

Lei Wan,Yu-An Hsu

DOI: https://doi.org/10.4049/jimmunol.192.supp.56.8

2014-01-01

Abstract:Galectin-12 (Gal12) is a member of a family of animal lectins. Gal12 is expressed in adipocytes and it has been shown to play an important role in adipocyte differentiation. We found that Gal12 is expressed in macrophages and the ablation of Gal12 did not influence bone marrow cells to differentiate into macrophages. The ablation of Gal12 reduced the phagocytic activity against E. coli and lowered the secretion of nitro oxide. Gal12 KO demonstrated the polarization of macrophages to M2 macrophages, as indicated by the increases in the expression levels of FIZZ1 and Ym1 as well as the reduction in the expression levels of TNF-α, IL-6, IL-12, IL-1β, MCP-1, and CXCL1 pro-inflammatory cytokines. We also detected a higher expression level of IL-10, an anti-inflammatory cytokine, in Gal12 KO macrophages. Moreover, the activation of IKKα/β, Akt and ERK was lower in Gal12 KO macrophages, which subsequently reduced the activation of NF-κB and AP1, resulting in lower expression levels of pro-inflammatory cytokines. The activation of STAT1 and STAT6 was lower in Gal12 KO macrophages, indicating that Gal12 may modulate the activation of the IRF3 and subsequently lower the expression of type I interferon by LPS treatment. The activation of STAT3 was much higher in Gal12 KO macrophages activated by LPS, which indicated higher expression levels of IL-10 in Gal12 KO macrophages. Our data indicates Gal12 KO predisposed macrophage to polarize into M2 macrophage.
Macrophage-restricted Tyrosine Phosphatase SHP2 is a Novel Anti-Atherosclerotic Regulator

Chenxia Wu,Chen Xu,Lan Ma,Wei Mao,Hongqiang Cheng,Yuehai Ke

DOI: https://doi.org/10.4049/jimmunol.204.supp.144.5

2020-01-01

Abstract:Abstract Atherosclerosis is a main pathological basis for cardiovascular diseases. Macrophages, featured in phenotypic and functional plasticity, play critical roles in initiation, progression, and regression of atherosclerosis. Our previously studies have shown that protein tyrosine phosphatase SHP2 regulates macrophage polarization, the immune homeostasis mediated by the interactions between macrophages and epithelial cells in mouse lung and intestine, and a tumor-favorable immune microenvironment. However, a potential role of SHP2 in atherosclerotic macrophages remains unknown. The expression of SHP2 is increased in macrophages within human atherosclerotic plaques. SHP2 allosteric inhibitor and macrophage-specific SHP2 deletion worsened atherosclerosis in ApoE null mice. Total cholesterol and low-density lipoprotein were increased in SHP2 inefficient mice. SHP2 inefficiency promoted inflammatory M1 polarization and inhibited anti-inflammatory M2 polarization, which was ApoE-null-dependent. Less cholesterol accumulation was observed in SHP2 inefficient macrophages and cholesterol transporter CD 36 was downregulated. To further explore the underlying mechanism, RNA sequencing was performed using SHP2 deleted macrophages with or without oxLDL treatment. Taken together, our studies using SHP2 knockout mice and specific inhibitor suggest that SHP2 is a novel anti-atherosclerotic regulator in promoting inflammatory macrophage phenotype.
Role of Galectin-3 in resident macrophages and effects on atherosclerosis

Y Li,R D Duan,X Blanchet,M N Jahantigh,R Su,C Schulz,A Schober,C Weber,P Von Hundelshausen

DOI: https://doi.org/10.1093/eurheartj/ehae666.1290

IF: 39.3

2024-10-28

European Heart Journal

Abstract:Background Arterial macrophages play an important role in atherosclerosis, exhibiting heterogeneity in their origins as either resident or inflammatory monocyte-derived macrophages. Resident macrophages originate predominantly from the yolk sac, and they are endowed with homeostatic functions and can have anti-inflammatory properties under inflammation [1]. Resident macrophages pre-existing within the tissue differentiate into foamy macrophages before monocytes appear in early atherosclerotic lesions [2]. Galectin-3 (Gal-3) encoded by the gene Lgals3, is a crucial effector molecule that is prominently expressed by macrophages [3]. Studies have provided conflicting evidence regarding the role of Gal-3 in atherosclerosis by affecting macrophage functions and monocyte recruitment [4,5]. Purpose This study aims to investigate the role of Gal-3 in arterial resident macrophages for atherosclerosis and reveal the underlying mechanisms. Methods General Lgals3 knockout (Lgals3-/-) and resident macrophage specific knockout (Lgals3-/-Rank-Cretg) mice on the Apoe-deficient background were generated and atherosclerotic lesion development (8 weeks of western diet) was compared. Results Our study revealed that Lgals3-/- mice exhibited increased numbers of monocytes and neutrophils in the blood, which was associated with the development of larger atherosclerotic plaques. Plasma Gal-3 concentration from Lgals3-/-Rank-Cretg mice was decreased by 60%, indicating that the majority of circulating Gal-3 is derived from resident macrophages. Surprisingly, Lgals3-/-Rank-Cretg mice did not show the observed increase in blood monocytes and neutrophils, suggesting that this effect was independent of circulating Gal-3. Consistent with a causal role of monocytosis and leukocytosis in atherogenesis, plaque formation in Lgals3-/-Rank-Cretg was not significantly affected. Additionally, Gal-3 deficiency promoted M1 polarization and reduced efferocytosis, phagocytosis and chemokine receptor expression in BMDMs, and the addition of exogenous Gal-3 restored the effect on phagocytosis and blocked CXCL12 and CCL5-induced leukocyte migration. Conclusion This study reveals a prominent protective role of Gal-3, primarily through inflammatory macrophages rather than resident macrophages for the development of atherosclerotic lesions. This protective effect is attributed to its homeostatic effects on monocyte and neutrophil numbers, as well as its influence on macrophage functions.

cardiac & cardiovascular systems
Galectin-9: A Suppressor of Atherosclerosis?

Jian Yu,Ruirui Zhu,Kuwu Yu,Yue Wang,Yan Ding,Yucheng Zhong,Qiutang Zeng,Kunwu Yu

DOI: https://doi.org/10.3389/fimmu.2020.604265

IF: 7.3

2020-11-04

Frontiers in Immunology

Abstract:It is no longer controversial that atherosclerosis is a vascular wall chronic inflammatory disease mediated by cells of innate and adaptive immunity. Galectin-9 (Gal-9) seems to be a crucial regulator of T-cell immunity by inducing apoptosis in specific T-cell subpopulations associated with autoimmunity and inflammatory disease. Accumulating evidence showed that galectin-9 signaling via T-cell immunoglobulin mucin 3 (TIM-3) is concerned with different regulatory functions in autoimmunity, including direct depletion of pro-inflammatory T-cells, expanding the number of regulatory T cells, altering macrophages to an anti-inflammatory state and the induction of repressive myeloid-derived suppressor cells. In addition, anti-Tim-3-Ab administration increased atherosclerotic plaque formation by blocking Tim-3–galectin-9 interaction. Hence, we hypothesize that galectin-9 may be a novel therapy for atherosclerotic disease. Further researches are needed to investigate the precise effect of galectin-9 in the process of atherosclerosis.

immunology
Modified Citrus Pectin Inhibits Galectin-3 Function to Reduce Atherosclerotic Lesions in Apoe-Deficient Mice.

Yonggang Lu,Mingming Zhang,Pei Zhao,Min Jia,Bing Liu,Qian Jia,Jun Guo,Lin Dou,Jian Li

DOI: https://doi.org/10.3892/mmr.2017.6646

IF: 3.423

2017-01-01

Molecular Medicine Reports

Abstract:Galectin-3 is a carbohydrate-binding lectin, which has been implicated in the modulation of atherosclerotic pathophysiology, and is highly expressed in monocytes, macrophages and endothelial cells within atherosclerotic plaques. Modified citrus pectin (MCP) is produced from citrus pectin via pH and temperature modifications, which break it into shorter, non-branched, galactose-rich carbohydrate chains. MCP is able to tightly bind with galectin-3, via recognition of its carbohydrate recognition domain, and facilitates the modulation of galectin-3-induced bioactivity. The present study explored the effects of MCP on the initiation of atherosclerosis. Eight-week-old apolipoprotein E-deficient mice were treated with 1% MCP and fed an atherogenic diet for 4 weeks. The effects of MCP on atherosclerotic initiation were determined by pathological analysis and scanning electron microscope (SEM) imaging. MCP treatment reduced the size of atherosclerotic lesion areas, which was accompanied by decreased numbers of macrophages and smooth muscle cells (SMCs). Furthermore, SEM examination of the surface of the atheroma-prone vessel wall indicated that MCP treatment reduced endothelial injury. To analyze the effects of MCP on monocyte adhesion, firstly, oxidized-low density lipoprotein and various concentrations of MCP (0.025, 0.05, 0.1 and 0.25%) were incubated with the human umbilical vein endothelial cells (HUVECs) for stimulation and following this, the U937 cells were plated onto the HUVECs. The results revealed that MCP reduced the adhesion of U937 monocytes to HUVECs, indicating the adhesion-inhibiting effects of MCP. In conclusion, the present study revealed that MCP, a galectin-3 inhibitor, reduced the size of atherosclerotic lesions by inhibiting the adhesion of leucocytes to endothelial cells. Inhibition of galectin-3 function may be a therapeutic strategy for the treatment of atherosclerosis.
Macrophage KLF15 prevents foam cell formation and atherosclerosis via transcriptional suppression of OLR-1

Zheng-Kun Song,Li Zhao,De-Shen Liu,Ling-Na Zhao,Qin-Bao Peng,Zi-Yao Li,Jia-Yong Wu,Si-Kai Chen,Fang-Ze Huang,Xing Chen,Tian-Xiao Lin,Li Guan,Wei-Peng Meng,Jia-Wei Guo,Yue-Nian Su,Xiao-Xia He,Si-Jia Liang,Peng Zhu,Shao-Yi Zheng,Song-Lin Du,Xiu Liu

DOI: https://doi.org/10.1016/j.yjmcc.2023.11.006

Abstract:Background: Macrophage-derived foam cells are a hallmark of atherosclerosis. Scavenger receptors, including lectin-like oxidized low-density lipoprotein (LDL) receptor-1 (OLR-1), are the principal receptors responsible for the uptake and modification of LDL, facilitating macrophage lipid load and the uptake of oxidized LDL by arterial wall cells. Krüppel-like factor 15 (KLF15) is a transcription factor that regulates the expression of genes by binding to the promoter during transcription. Therefore, this study aimed to investigate the precise role of macrophage KLF15 in atherogenesis. Methods: We used two murine models of atherosclerosis: mice injected with an adeno-associated virus (AAV) encoding the Asp374-to-Tyr mutant version of human PCSK9, followed by 12 weeks on a high-fat diet (HFD), and ApoE-/-- mice on a HFD. We subsequently injected mice with AAV-KLF15 and AAV-LacZ to assess the role of KLF15 in the development of atherosclerosis in vivo. Oil Red O, H&E, and Masson's trichome staining were used to evaluate atherosclerotic lesions. Western blots and RT-qPCR were used to assess protein and mRNA levels, respectively. Results: We determined that KLF15 expression was downregulated during atherosclerosis formation, and KLF15 overexpression prevented atherosclerosis progression. KLF15 expression levels did not affect body weight or serum lipid levels in mice. However, KLF15 overexpression in macrophages prevented foam cell formation by reducing OLR-1-meditated lipid uptake. KLF15 directly targeted and transcriptionally downregulated OLR-1 levels. Restoration of OLR-1 reversed the beneficial effects of KLF15 in atherosclerosis. Conclusion: Macrophage KLF15 transcriptionally downregulated OLR-1 expression to reduce lipid uptake, thereby preventing foam cell formation and atherosclerosis. Thus, our results suggest that KLF15 is a potential therapeutic target for atherosclerosis.
Galectin-1 accelerates high-fat diet-induced obesity by activation of peroxisome proliferator-activated receptor gamma (PPARγ) in mice

Jung-Hwan Baek,Da-Hyun Kim,Jaegyeong Lee,Seok-Jun Kim,Kyung-Hee Chun

DOI: https://doi.org/10.1038/s41419-020-03367-z

2021-01-11

Abstract:Galectin-1 contains a carbohydrate-recognition domain (CRD) as a member of the lectin family. Here, we investigated whether galectin-1 regulates adipogenesis and lipid accumulation. Galectin-1 mRNA is highly expressed in metabolic tissues such as the muscle and adipose tissues. Higher mRNA expression of galectin-1 was detected in white adipose tissues (WATs) of mice that were fed a high-fat diet (HFD) than in those of mice fed a normal-fat diet (NFD). Protein expression of galectin-1 also increased during adipocyte differentiation. Galectin-1 silencing inhibited the differentiation of 3T3-L1 cells and the expression of lipogenic factors, such as PPARγ, C/EBPα, FABP4, and FASN at both mRNA and protein levels. Lactose, an inhibitor by the binding with CRD of galectin-1 in extracellular matrix, did not affect adipocyte differentiation. Galectin-1 is localized in multiple cellular compartments in 3T3-L1 cells. However, we found that DMI (dexamethasone, methylisobutylxanthine, insulin) treatment increased its nuclear localization. Interestingly, galectin-1 interacted with PPARγ. Galectin-1 overexpression resulted in increased PPARγ expression and transcriptional activity. Furthermore, we prepared galectin-1-knockout (Lgals1-/-) mice and fed a 60% HFD. After 10 weeks, Lgals1-/- mice exhibited lower body weight and gonadal WAT (gWAT) mass than wild-type mice. Fasting glucose level was also lower in Lgals1-/-mice than that in wild-type mice. Moreover, lipogenic genes were significantly downregulated in the gWATs and liver tissues from Lgals1-/- mice. Pro-inflammatory cytokines, such as CCL2, CCL3, TNFα, and F4/80, as well as macrophage markers, were also drastically downregulated in the gWATs and liver tissues of Lgals1-/- mice. In addition, Lgals1-/-mice showed elevated expression of genes involved in thermogenesis in the brown adipose tissue. Collectively, galectin-1 exacerbates obesity of mice fed HFD by increment of PPARγ expression and activation. Our findings suggest that galectin-1 could be a potential therapeutic target for obesity and needed further study for clinical application.
Galectin-1 prevents pathological vascular remodeling in atherosclerosis and abdominal aortic aneurysm

Raquel Roldán-Montero,Isabel Cerro-Pardo,Jorge Oller,Diego Martinez-Lopez,Estefania Nuñez,Carmen Gutierrez-Muñoz,Nerea Mendez-Barbero,Jean-Baptiste Michel,Maria Mittelbrunn,Jesús Vázquez,Juan M. Pérez-Sáez,Sebastian M. Maller,Joan C. Escola-Gil,Luis M. Blanco-Colio,Gabriel A. Rabinovich,Jose L. Martin-Ventura

DOI: https://doi.org/10.1126/sciadv.abm7322

IF: 13.6

2022-03-18

Science Advances

Abstract:Pathological vascular remodeling is the underlying cause of atherosclerosis and abdominal aortic aneurysm (AAA). Here, we analyzed the role of galectin-1 (Gal-1), a β-galactoside–binding protein, as a therapeutic target for atherosclerosis and AAA. Mice lacking Gal-1 ( Lgals1 −/− ) developed severe atherosclerosis induced by pAAV/D377Y-mPCSK9 adenovirus and displayed higher lipid levels and lower expression of contractile markers of vascular smooth muscle cells (VSMCs) in plaques than wild-type mice. Proteomic analysis of Lgals1 −/− aortas showed changes in markers of VSMC phenotypic switch and altered composition of mitochondrial proteins. Mechanistically, Gal-1 silencing resulted in increased foam cell formation and mitochondrial dysfunction in VSMCs, while treatment with recombinant Gal-1 (rGal-1) prevented these effects. Furthermore, rGal-1 treatment attenuated atherosclerosis and elastase-induced AAA, leading to higher contractile VSMCs in aortic tissues. Gal-1 expression decreased in human atheroma and AAA compared to control tissue. Thus, Gal-1–driven circuits emerge as potential therapeutic strategies in atherosclerosis and AAA.

multidisciplinary sciences
Deficiency of LMP10 Attenuates Diet-Induced Atherosclerosis by Inhibiting Macrophage Polarization and Inflammation in Apolipoprotein E Deficient Mice

Jiawei Liao,Xiangbo An,Xiaolei Yang,Qiu-Yue Lin,Shuang Liu,Yunpeng Xie,Jie Bai,Yun-Long Xia,Hui-Hua Li

DOI: https://doi.org/10.3389/fcell.2020.592048

IF: 5.5

2020-10-23

Frontiers in Cell and Developmental Biology

Abstract:Macrophage polarization and inflammation are key factors for the onset and progression of atherosclerosis. The immunoproteasome complex consists of three inducible catalytic subunits (LMP2, LMP10, and LMP7) that play a critical role in the regulation of these risk factors. We recently demonstrated that the LMP7 subunit promotes diet-induced atherosclerosis via inhibition of MERTK-mediated efferocytosis. Here, we explored the role of another subunit of LMP10 in the disease process, using ApoE knockout (ko) mice fed on an atherogenic diet (ATD) containing 0.5% cholesterol and 20% fat for 8 weeks as an in vivo atherosclerosis model. We observed that ATD significantly upregulated LMP10 expression in aortic lesions, which were primarily co-localized with plaque macrophages. Conversely, deletion of LMP10 markedly attenuated atherosclerotic lesion area, CD68+ macrophage accumulation, and necrotic core expansion in the plaques, but did not change plasma metabolic parameters, lesional SM22α+ smooth muscle cells, or collagen content. Myeloid-specific deletion of LMP10 by bone marrow transplantation resulted in similar phenotypes. Furthermore, deletion of LMP10 remarkably reduced aortic macrophage infiltration and increased M2/M1 ratio, accompanied by decreased expression of pro-inflammatory M1 cytokines (MCP-1, IL-1, and IL-6) and increased expression of anti-inflammatory M2 cytokines (IL-4 and IL-10). In addition, we confirmed in cultured macrophages that LMP10 deletion blunted macrophage polarization and inflammation during ox-LDL-induced foam cell formation in vitro, which was associated with decreased IκBα degradation and NF-κB activation. Our results show that the immunoproteasome subunit LMP10 promoted diet-induced atherosclerosis in ApoE ko mice possibly through regulation of NF-κB-mediated macrophage polarization and inflammation. Targeting LMP10 may represent a new therapeutic approach for atherosclerosis.

cell biology,developmental biology
Endothelial Gata6 deletion reduces monocyte recruitment and proinflammatory macrophage formation and attenuates atherosclerosis through Cmpk2-Nlrp3 pathways

Wenrun Wu,Wenzhen Bao,Xiaoli Chen,Yushi Lu,Ji Fang,Jiwen Liu,Sheng Peng,Jingjiang Pi,Brain Tomlinson,Paul Chan,Qi Zhang,Lin Zhang,Zhongmin Liu,Jie Liu,Yuzhen Zhang,Tao Zhuang

DOI: https://doi.org/10.1016/j.redox.2023.102775

IF: 11.4

2023-06-13

Redox Biology

Abstract:Endothelial dysfunction results in chronic vascular inflammation, which is critical for the development of atherosclerotic diseases. Transcription factor Gata6 has been reported to regulate vascular endothelial cell activation and inflammation in vitro . Here, we aimed to explore the roles and mechanisms of endothelial Gata6 in atherogenesis. Endothelial cell (EC) specific Gata6 deletion was generated in the Apoe KO hyperlipidemic atherosclerosis mouse model. Atherosclerotic lesion formation, endothelial inflammatory signaling, and endothelial-macrophage interaction were examined in vivo and in vitro by using cellular and molecular biological approaches. EC-GATA6 deletion mice exhibited a significant decrease in monocyte infiltration and atherosclerotic lesion compared to littermate control mice. Cytosine monophosphate kinase 2 (Cmpk2) was identified as a direct target gene of GATA6 and EC-GATA6 deletion decreased monocyte adherence, migration and pro-inflammatory macrophage foam cell formation through regulation of the CMPK2-Nlrp3 pathway. Endothelial target delivery of Cmpk2-shRNA by intercellular adhesion molecule 2 (Icam-2) promoter-driven AAV9 carrying the shRNA reversed the Gata6 upregulation mediated elevated Cmpk2 expression and further Nlrp3 activation and thus attenuated atherosclerosis. In addition, C–C motif chemokine ligand 5 (Ccl5) was also identified as a direct target gene of Gata6 to regulate monocyte adherence and migration influencing atherogenesis. This study provides direct in vivo evidence of EC-GATA6 involvement in the regulation of Cmpk2-Nlrp3, as well as Ccl5, on monocyte adherence and migration in atherosclerosis development and advances our understanding of the in vivo mechanisms of atherosclerotic lesion development, and meanwhile provides opportunities for future therapeutic interventions.

biochemistry & molecular biology
Gsα Regulates Macrophage Foam Cell Formation During Atherosclerosis

Chang Ma,Yihui Li,Mi Tian,Qiming Deng,Qin Xiaoteng,Hanlin Lu,Jiangang Gao,Min Chen,Lee S Weinstein,Mei Zhang,Peili Bu,Jianmin Yang,Yun Zhang,Cheng Zhang,Wencheng Zhang,Chang MaYihui LiMi TianQiming DengQin XiaotengHanlin LuJiangang GaoMin ChenLee S. WeinsteinMei ZhangPeili BuJianmin YangYun ZhangCheng ZhangWencheng ZhangNational Key Laboratory for Innovation and Transformation of Luobing Theory; The Key Laboratory of Cardiovascular Remodeling and Function Research,Chinese Ministry of Education,Chinese National Health Commission and Chinese Academy of Medical Sciences; Department of Cardiology,Qilu Hospital of Shandong University,Jinan,China (C.M.,Y.L.,Q.D.,X.Q.,H.L.,M.Z.,P.B.,J.Y.,Y.Z.,C.Z.,W.Z.).Department of Critical Care Medicine,Qilu Hospital,Cheeloo College of Medicine,Shandong University,Jinan,China. (Y.L.)School of Life Science and Key Laboratory of the Ministry of Education for Experimental Teratology,Shandong University,Jinan,China. (J.G.)Department of Cardiology,The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital,Shandong Medicine and Health Key Laboratory of Cardiac Electrophysiology and Arrhythmia,Jinan,China (M.T.).Metabolic Diseases Branch,National Institute of Diabetes,Digestive,and Kidney Diseases,National Institutes of Health,Bethesda,MD (M.C.,L.S.W.).

DOI: https://doi.org/10.1161/circresaha.123.323156

IF: 23.213

2024-02-21

Circulation Research

Abstract:Circulation Research, Ahead of Print. Background:Many cardiovascular pathologies are induced by signaling through G-protein-coupled receptors via Gsα (G protein stimulatory α subunit) proteins. However, the specific cellular mechanisms that are driven by Gsα and contribute to the development of atherosclerosis remain unclear.Methods:High-throughput screening involving data from single-cell and bulk sequencing were used to explore the expression of Gsα in atherosclerosis. The differentially expression and activity of Gsα were analyzed by immunofluorescence and cAMP measurements. Macrophage-specific Gsα knockout (Mac-GsαKO) mice were generated to study the effect on atherosclerosis. The role of Gsα was determined by transplanting bone marrow and performing assays for foam cell formation, Dil-ox-LDL (oxidized low-density lipoprotein) uptake, chromatin immunoprecipitation, and luciferase reporter assays.Results:ScRNA-seq showed elevatedGnasin atherosclerotic mouse aorta's cholesterol metabolism macrophage cluster, while bulk sequencing confirmed increasedGNASexpression in human plaque macrophage content. A significant upregulation of Gsα and active Gsα occurred in macrophages from human and mouse plaques. Ox-LDL could translocate Gsα from macrophage lipid rafts in short-term and promoteGnastranscription through ERK1/2 activation and C/EBPβ phosphorylation via oxidative stress in long-term. Atherosclerotic lesions from Mac-GsαKOmice displayed decreased lipid deposition compared with those from control mice. Additionally, Gsα deficiency alleviated lipid uptake and foam cell formation. Mechanistically, Gsα increased the levels of cAMP and transcriptional activity of the cAMP response element binding protein, which resulted in increased expression of CD36 and SR-A1. In the translational experiments, inhibiting Gsα activation with suramin or cpGN13 reduced lipid uptake, foam cell formation, and the progression of atherosclerotic plaques in mice in vivo.Conclusions:Gsα activation is enhanced during atherosclerotic progression and increases lipid uptake and foam cell formation. The genetic or chemical inactivation of Gsα inhibit the development of atherosclerosis in mice, suggesting that drugs targeting Gsα may be useful in the treatment of atherosclerosis.

cardiac & cardiovascular systems,peripheral vascular disease,hematology
Single-Cell Analysis Reveals Critical Role of Macrophage Epsin in Regulating Origin of Foam Cell in Atherosclerosis

Kulandaisamy Arulsamy,Kui Cui,Xinlei Gao,Anna Voronova,Kaifu Chen,Hong Chen

DOI: https://doi.org/10.1101/2024.08.29.610301

2024-09-01

Abstract:Atherosclerosis is a chronic inflammatory condition characterized by the excessive accumulation of fat and lipid molecules, leading to the formation of foam cells and plaques in arterial walls. Dysfunction of vascular smooth muscle cells (VSMCs), fibroblast, endothelial cells, and macrophages is often associated with this pathology. We found that epsins accelerate atherosclerosis progression in individuals on a Western diet (WD). Using ApoE-deficient (ApoE ) and macrophage-specific epsin deletion in ApoE-/- backgrounds (LysM-DKO/ApoE ) mice fed a WD for 16 weeks, we observed significantly reduced foam cell formation in LysM-DKO/ApoE mice compared to ApoE mice. Single-cell RNA sequencing identified 20 major cell types, including seven VSMC and five macrophage subtypes. Among the VSMC subtypes, modulating VSMC1 was involved in inflammation and migration, while modulating VSMC2 was associated with VSMC phenotype switching. In atherosclerotic mice, populations of modulating VSMC1, VSMC2, foamy-Trem2, and inflammatory macrophages increased, but significantly decreased in epsin-deficient mice. Modulating VSMC2 transition into macrophages occurred with a probability of 0.57 in ApoE mice, compared to 0.01 in LysM-DKO/ApoE mice. Epsin deletion also reversed endothelial dysfunction and downregulated cholesterol and glucose-mediated signals, as well as inflammatory ligands Il1b and C1qa. Our findings suggest that epsin deletion reduces foam cell formation and rewires VSMC and endothelial functions, offering a novel therapeutic strategy for atherosclerosis.

Cell Biology
Ganoderic acids alleviate atherosclerosis by inhibiting macrophage M1 polarization via TLR4/MyD88/NF-κB signaling pathway

Ya-zhu Quan,Ang Ma,Chao-qun Ren,Yong-pan An,Pan-shuang Qiao,Cai Gao,Yu-kun Zhang,Xiao-wei Li,Si-mei Lin,Nan-nan Li,Di-long Chen,Yan Pan,Hong Zhou,Dong-mei Lin,Shu-qian Lin,Min Li,Bao-xue Yang

DOI: https://doi.org/10.1016/j.atherosclerosis.2024.117478

IF: 5.3

2024-02-11

Atherosclerosis

Abstract:Background and aims Atherosclerosis (AS) is a chronic inflammatory disease characterized by lipid infiltration and plaque formation in blood vessel wall. Ganoderic acids (GA), a class of major bioactive compounds isolated from the Chinese traditional medicine Ganoderma lucidum, have multiple pharmacological activities. This study aimed to determine the anti-atherosclerotic effect of GA and reveal the pharmacological mechanism. Methods ApoE -/- mice were fed a high-cholesterol diet and treated with GA for 16 weeks to induce AS and identify the effect of GA. Network pharmacological analysis was performed to predict the anti-atherosclerotic mechanisms. In vitro cell model was used to explore the effect of GA on macrophage polarization and the possible mechanism involved in BMDMs and RAW264.7 cells stimulated with lipopolysaccharide or oxidized low-density lipoprotein. Results It was found that GA at 5 and 25 mg/kg/d significantly inhibited the development of AS and increased plaque stability, as evidenced by the decreased plaque in the aorta, reduced necrotic core size and increased collagen/lipid ratio in lesions. GA reduced the proportion of M1 macrophages in plaques, but had no effect on M2 macrophages. In vitro experiments showed that GA (1, 5, 25 μg/mL) significantly decreased the proportion of CD86 + macrophage and the mRNA levels of IL-6, IL-1β, and MCP-1 in macrophage. Experimental results showed that GA inhibited M1 macrophage polarization by regulating TLR4/MyD88/NF-κB signaling pathway. Conclusions This study demonstrated that GA play an important role in plaque stability and macrophage polarization. GA exerted the anti-atherosclerotic effect partly by regulating TLR4/MyD88/NF-κB signaling pathways to inhibit the M1 polarization of macrophages. Our study provides theoretical basis and experimental data for the pharmacological activity and mechanisms of GA against AS.

cardiac & cardiovascular systems,peripheral vascular disease
Galectin-12 modulates sebocyte proliferation and cell cycle progression by regulating cyclin A1 and CDK2

Ching-Han Tsao,Wei-Chen Hsieh,Ri-Yao Yang,Yuan-Hsin Lo,Ting-Jui Tu,Liang-Yin Ke,Christos C Zouboulis,Fu-Tong Liu

DOI: https://doi.org/10.1093/glycob/cwab100

2022-02-26

Glycobiology

Abstract:Enhanced sebocyte proliferation is associated with the pathogenesis of human skin diseases related to sebaceous gland hyperfunction and androgens, which are known to induce sebocyte proliferation, are key mediators of this process. Galectin-12, a member of the β-galactoside-binding lectin family that is preferentially expressed by adipocytes and functions as an intrinsic negative regulator of lipolysis, has been shown to be expressed by human sebocytes. In this study, we identified galectin-12 as an important intracellular regulator of sebocyte proliferation. Galectin-12 knockdown in the human SZ95 sebocyte line suppressed cell proliferation, and its overexpression promoted cell cycle progression. Inhibition of galectin-12 expression reduced the androgen-induced SZ95 sebocyte proliferation and growth of sebaceous glands in mice, respectively. The mRNA expression of the key cell cycle regulators cyclin A1 (CCNA1) and cyclin-dependent kinase 2CDK2 was reduced in galectin-12 knockdown SZ95 sebocytes, suggesting a pathway of galectin-12 regulation of sebocyte proliferation. Further, galectin-12 enhanced peroxisome proliferator-activated receptor gamma (PPARγ) expression and transcriptional activity in SZ95 sebocytes, consistent with our previous studies in adipocytes. Rosiglitazone, a PPARγ ligand, induced CCNA1 levels, suggesting that galectin-12 may upregulate CCNA1 expression via PPARγ. Our findings suggest the possibility of targeting galectin-12 to treat human sebaceous gland hyperfunction and androgen-associated skin diseases.
Siglec-E retards atherosclerosis by inhibiting CD36-mediated foam cell formation

Yaw-Wen Hsu,Fu-Fei Hsu,Ming-Tsai Chiang,Dong-Lin Tsai,Fu-An Li,Takashi Angata,Paul R. Crocker,Lee-Young Chau

DOI: https://doi.org/10.1186/s12929-020-00698-z

2021-01-05

Journal of Biomedical Science

Abstract:Abstract Background The accumulation of lipid-laden macrophages, foam cells, within sub-endothelial intima is a key feature of early atherosclerosis. Siglec-E, a mouse orthologue of human Siglec-9, is a sialic acid binding lectin predominantly expressed on the surface of myeloid cells to transduce inhibitory signal via recruitment of SH2-domain containing protein tyrosine phosphatase SHP-1/2 upon binding to its sialoglycan ligands. Whether Siglec-E expression on macrophages impacts foam cell formation and atherosclerosis remains to be established. Methods ApoE-deficient (apoE −/− ) and apoE/Siglec-E-double deficient (apoE −/− /Siglec-E −/− ) mice were placed on high fat diet for 3 months and their lipid profiles and severities of atherosclerosis were assessed. Modified low-density lipoprotein (LDL) uptake and foam cell formation in wild type (WT) and Siglec-E −/− - peritoneal macrophages were examined in vitro. Potential Siglec-E-interacting proteins were identified by proximity labeling in conjunction with proteomic analysis and confirmed by coimmunoprecipitation experiment. Impacts of Siglec-E expression and cell surface sialic acid status on oxidized LDL uptake and signaling involved were examined by biochemical assays. Results Here we show that genetic deletion of Siglec-E accelerated atherosclerosis without affecting lipid profile in apoE −/− mice. Siglec-E deficiency promotes foam cell formation by enhancing acetylated and oxidized LDL uptake without affecting cholesterol efflux in macrophages in vitro. By performing proximity labeling and proteomic analysis, we identified scavenger receptor CD36 as a cell surface protein interacting with Siglec-E. Further experiments performed in HEK293T cells transiently overexpressing Siglec-E and CD36 and peritoneal macrophages demonstrated that depletion of cell surface sialic acids by treatment with sialyltransferase inhibitor or sialidase did not affect interaction between Siglec-E and CD36 but retarded Siglec-E-mediated inhibition on oxidized LDL uptake. Subsequent experiments revealed that oxidized LDL induced transient Siglec-E tyrosine phosphorylation and recruitment of SHP-1 phosphatase in macrophages. VAV, a downstream effector implicated in CD36-mediated oxidized LDL uptake, was shown to interact with SHP-1 following oxidized LDL treatment. Moreover, oxidized LDL-induced VAV phosphorylation was substantially lower in WT macrophages comparing to Siglec-E −/− counterparts. Conclusions These data support the protective role of Siglec-E in atherosclerosis. Mechanistically, Siglec-E interacts with CD36 to suppress downstream VAV signaling involved in modified LDL uptake.

cell biology,medicine, research & experimental
Myocardin related transcription factor and galectin-3 drives lipid accumulation in human blood vessels

Marycarmen Arévalo-Martinez,Jacob Ede,Oscar van der Have,Olivia Ritsvall,Fredrik R. Zetterberg,Ulf J. Nilsson,Hakon Leffler,Johan Holmberg,Sebastian Albinsson

DOI: https://doi.org/10.1016/j.vph.2024.107383

IF: 5.738

2024-06-04

Vascular Pharmacology

Abstract:Objective Diabetes and hypertension are important risk factors for vascular disease, including atherosclerosis. A driving factor in this process is lipid accumulation in smooth muscle cells of the vascular wall. The glucose- and mechano-sensitive transcriptional coactivator, myocardin-related transcription factor A (MRTF-A/MKL1) can promote lipid accumulation in cultured human smooth muscle cells and contribute to the formation of smooth muscle-derived foam cells. The purpose of this study was to determine if intact human blood vessels ex vivo can be used to evaluate lipid accumulation in the vascular wall, and if this process is dependent on MRTF and/or galectin-3/ LGALS3 . Galectin-3 is an early marker of smooth muscle transdifferentiation and a potential mediator for foam cell formation and atherosclerosis. Approach and results Human mammary arteries and saphenous veins were exposed to altered cholesterol and glucose levels in an organ culture model. Accumulation of lipids, quantified by Oil Red O, was increased by cholesterol loading and elevated glucose concentrations. Pharmacological inhibition of MRTF with CCG-203971 decreased lipid accumulation, whereas adenoviral-mediated overexpression of MRTF-A had the opposite effect. Cholesterol-induced expression of galectin-3 was decreased after inhibition of MRTF. Importantly, pharmacological inhibition of galectin-3 with GB1107 reduced lipid accumulation in the vascular wall after cholesterol loading. Conclusion Ex vivo organ culture of human arteries and veins can be used to evaluate lipid accumulation in the intact vascular wall, as well as adenoviral transduction and pharmacological inhibition. Although MRTF and galectin-3 may have beneficial, anti-inflammatory effects under certain circumstances, our results, which demonstrate a significant decrease in lipid accumulation, support further evaluation of MRTF- and galectin-3-inhibitors for therapeutic intervention against atherosclerotic vascular disease.

pharmacology & pharmacy
Feeding Angptl4−/− Mice Trans Fat Promotes Foam Cell Formation in Mesenteric Lymph Nodes Without Leading to Ascites

Antwi-Boasiako Oteng,Asmita Bhattacharya,Susanne Brodesser,Ling Qi,Nguan Soon Tan,Sander Kersten

DOI: https://doi.org/10.1194/jlr.m074278

IF: 6.676

2017-01-01

Journal of Lipid Research

Abstract:Angiopoietin-like 4 (ANGPTL4) regulates plasma triglyceride levels by inhibiting LPL. Inactivation of ANGPTL4 decreases plasma triglycerides and reduces the risk of coronary artery disease. Unfortunately, targeting ANGPTL4 for the therapeutic management of dyslipidemia and atherosclerosis is hampered by the observation that mice and monkeys in which ANGPTL4 is inactivated exhibit lipid accumulation in the mesenteric lymph nodes (MLNs). In mice these pathological events exclusively unfold upon feeding a high saturated FA diet and are followed by an ultimately lethal pro-inflammatory response and chylous ascites. Here, we show that Angptl4−/− mice fed a diet rich in trans FAs develop numerous lipid-filled giant cells in their MLNs, yet do not have elevated serum amyloid and haptoglobin, do not exhibit ascites, and survive, unlike Angptl4−/− mice fed a saturated FA-rich diet. In RAW264.7 macrophages, the saturated FA, palmitate, markedly increased markers of inflammation and the unfolded protein response, whereas the trans-unsaturated elaidate and the cis-unsaturated oleate had the opposite effect. In conclusion, trans and saturated FAs have very distinct biological effects in macrophages. Furthermore, lipid accumulation in MLNs is uncoupled from activation of an acute-phase response and chylous ascites, suggesting that ANGPTL4 should not be fully dismissed as target for dyslipidemia.

[Mortality and survival of premature infants according to sex].

Galectin-12 modulates Kupffer cell polarization to alter the progression of nonalcoholic fatty liver disease

Leukocyte Cell-Derived Chemotaxin 2 Inhibits Development of Atherosclerosis in Mice

Galectin-12 in Cellular Differentiation, Apoptosis and Polarization

Galectin-12 in Macrophage Polarization (INM2P.425)

Macrophage-restricted Tyrosine Phosphatase SHP2 is a Novel Anti-Atherosclerotic Regulator

Role of Galectin-3 in resident macrophages and effects on atherosclerosis

Galectin-9: A Suppressor of Atherosclerosis?

Modified Citrus Pectin Inhibits Galectin-3 Function to Reduce Atherosclerotic Lesions in Apoe-Deficient Mice.

Macrophage KLF15 prevents foam cell formation and atherosclerosis via transcriptional suppression of OLR-1

Galectin-1 accelerates high-fat diet-induced obesity by activation of peroxisome proliferator-activated receptor gamma (PPARγ) in mice

Galectin-1 prevents pathological vascular remodeling in atherosclerosis and abdominal aortic aneurysm

Deficiency of LMP10 Attenuates Diet-Induced Atherosclerosis by Inhibiting Macrophage Polarization and Inflammation in Apolipoprotein E Deficient Mice

Endothelial Gata6 deletion reduces monocyte recruitment and proinflammatory macrophage formation and attenuates atherosclerosis through Cmpk2-Nlrp3 pathways

Gsα Regulates Macrophage Foam Cell Formation During Atherosclerosis

Single-Cell Analysis Reveals Critical Role of Macrophage Epsin in Regulating Origin of Foam Cell in Atherosclerosis

Ganoderic acids alleviate atherosclerosis by inhibiting macrophage M1 polarization via TLR4/MyD88/NF-κB signaling pathway

Galectin-12 modulates sebocyte proliferation and cell cycle progression by regulating cyclin A1 and CDK2

Siglec-E retards atherosclerosis by inhibiting CD36-mediated foam cell formation

Myocardin related transcription factor and galectin-3 drives lipid accumulation in human blood vessels

Feeding Angptl4−/− Mice Trans Fat Promotes Foam Cell Formation in Mesenteric Lymph Nodes Without Leading to Ascites